Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Spectral AI ( (MDAI) ) has issued an announcement.
Spectral AI, Inc., a Dallas-based predictive AI medical diagnostics company, develops the DeepView System, a non-invasive device intended to provide clinicians with immediate, algorithm-driven assessments of burn wounds to improve treatment decisions and lower healthcare costs. The company focuses on advancing wound care standards, initially in burn care, and has been recognized on TIME’s 2025 list of the World’s Top HealthTech companies.
On February 9, 2026, Spectral AI’s board appointed Vincent S. Capone as Chief Executive Officer and simultaneously dissolved the Office of the Chairman, formalizing the leadership transition as the company moves toward commercialization of the DeepView System. Capone, previously the firm’s Chief Financial Officer and General Counsel and a member of the Office of the Chairman, brings more than two decades of legal, financial, and operational experience, and his promotion signals an effort to align executive leadership with Spectral AI’s next phase of clinical development and market entry.
The most recent analyst rating on (MDAI) stock is a Buy with a $6.00 price target. To see the full list of analyst forecasts on Spectral AI stock, see the MDAI Stock Forecast page.
Spark’s Take on MDAI Stock
According to Spark, TipRanks’ AI Analyst, MDAI is a Neutral.
The score is held down primarily by weak financial performance (revenue contraction, large losses, negative equity, and ongoing cash burn). Technicals provide a partial offset with improving near-term momentum, while valuation remains constrained by unprofitability and no dividend support. The latest earnings call was mixed, with solid liquidity and FDA progress outweighed by reduced guidance and worsening near-term profitability.
To see Spark’s full report on MDAI stock, click here.
More about Spectral AI
Spectral AI, Inc. is a Dallas-based predictive artificial intelligence company specializing in medical diagnostics to enable faster and more accurate treatment decisions in wound care, initially targeting burn patients. Its core product, the proprietary, non-invasive DeepView System, is being developed as an AI-driven burn wound assessment device designed to objectively and immediately evaluate a wound’s healing potential while aiming to surpass the current standard of care and reduce healthcare costs.
The DeepView System uses algorithm-driven analysis to give clinicians rapid treatment insight before intervention, supporting value-based care by improving outcomes and lowering expenses. Spectral AI’s focus on revolutionizing wound management under the banner of “Seeing the Unknown” has gained industry recognition, including being named to TIME’s 2025 list of the World’s Top HealthTech companies, underscoring its growing prominence in the health technology sector.
Average Trading Volume: 358,420
Technical Sentiment Signal: Sell
Current Market Cap: $46.65M
Find detailed analytics on MDAI stock on TipRanks’ Stock Analysis page.